Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Am J Physiol Legacy Content 67(1):5764
Bariatric surgery was modelled as a potential subsequent treatment option for patients not meeting therapeutic goals under non-surgical management, and could occur in either arm, independent of initial assignment (semaglutide 2.4 mg plus D&E or D&E alone), applying Spain-specific eligibility criteria (minimum BMI threshold and maximum age) and a low annual national incidence rate reflecting limited capacity and waiting lists (Table S7)
GillTWatlingSERichardsonJDMcCluskeyTTongJMeyerJHet al
It is currently in a phase-3 trial, which is set to finish by early 2026
US$ 29.09
US$ 23.29
US$ 28.45
US$ 24.46
